FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

713465004: Dolutegravir sodium (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2016. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3297512018 Dolutegravir sodium en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3297665018 Dolutegravir sodium (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
807041000172112 dolutégravir sodique fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Belgian module (core metadata concept)
807051000172114 dolutegravirnatrium nl Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Belgian module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dolutegravir sodium Is a Dolutegravir false Inferred relationship Some
Dolutegravir sodium Has disposition (attribute) Integrase strand transfer inhibitor (disposition) true Inferred relationship Some
Dolutegravir sodium Is modification of (attribute) Dolutegravir true Inferred relationship Some
Dolutegravir sodium Is a Pyrimidine and/or pyrimidine derivative true Inferred relationship Some
Dolutegravir sodium Is a Nucleotidyltransferase inhibitor false Inferred relationship Some
Dolutegravir sodium Is a Integrase strand transfer inhibitor true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Dolutegravir (as dolutegravir sodium) 10 mg oral tablet Has precise active ingredient True Dolutegravir sodium Inferred relationship Some 1
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Dolutegravir sodium Inferred relationship Some 1
Product containing precisely dolutegravir (as dolutegravir sodium) 25 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Dolutegravir sodium Inferred relationship Some 1
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Dolutegravir sodium Inferred relationship Some 3
Product containing precisely abacavir (as abacavir sulfate) 600 milligram and dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Dolutegravir sodium Inferred relationship Some 3
Product containing precisely dolutegravir (as dolutegravir sodium) 5 milligram/1 each conventional release orodispersible tablet (clinical drug) Has precise active ingredient True Dolutegravir sodium Inferred relationship Some 1
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Dolutegravir sodium Inferred relationship Some 2
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and rilpivirine (as rilpivirine hydrochloride) 25 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Dolutegravir sodium Inferred relationship Some 2

Reference Sets

Belgian subset for AllergyIntolerance, causative agent, drug

Back to Start